IL-7: a potential next-generation adjuvant for immune cell therapies.

Saved in:
Bibliographic Details
Title: IL-7: a potential next-generation adjuvant for immune cell therapies.
Authors: Hotchkiss RS; Department of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine, St. Louis, MO, United States., DiPersio JF; Department of Medicine, Washington University School of Medicine, St Louis, MO, United States., Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Pachynski RK; Department of Medicine, Washington University School of Medicine, St Louis, MO, United States., Van Den Brink MRM; City of Hope Los Angeles and National Medical Center, Duarte, CA, United States.
Source: Frontiers in immunology [Front Immunol] 2026 Jan 02; Vol. 16, pp. 1736931. Date of Electronic Publication: 2026 Jan 02 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41550947
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: IL-7: a potential next-generation adjuvant for immune cell therapies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hotchkiss+RS%22">Hotchkiss RS</searchLink>; Department of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine, St. Louis, MO, United States.<br /><searchLink fieldCode="AU" term="%22DiPersio+JF%22">DiPersio JF</searchLink>; Department of Medicine, Washington University School of Medicine, St Louis, MO, United States.<br /><searchLink fieldCode="AU" term="%22Yee+C%22">Yee C</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Pachynski+RK%22">Pachynski RK</searchLink>; Department of Medicine, Washington University School of Medicine, St Louis, MO, United States.<br /><searchLink fieldCode="AU" term="%22Van+Den+Brink+MRM%22">Van Den Brink MRM</searchLink>; City of Hope Los Angeles and National Medical Center, Duarte, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Jan 02; Vol. 16, pp. 1736931. <i>Date of Electronic Publication: </i>2026 Jan 02 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41550947
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1736931
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1736931
    Titles:
      – TitleFull: IL-7: a potential next-generation adjuvant for immune cell therapies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hotchkiss RS
      – PersonEntity:
          Name:
            NameFull: DiPersio JF
      – PersonEntity:
          Name:
            NameFull: Yee C
      – PersonEntity:
          Name:
            NameFull: Pachynski RK
      – PersonEntity:
          Name:
            NameFull: Van Den Brink MRM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 01
              Text: 2026 Jan 02
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1